- In January 2025, 10x Genomics launched the Xenium Ranger platform, a high-throughput in situ analysis system for subcellular spatial mapping of gene expression. With enhanced resolution and multiplexing capabilities, it supports research into complex diseases such as cancer and neurodegenerative disorders, advancing discoveries in spatial genomics through scalable insights from intact tissue samples
- In November 2024, Berkeley Lights Inc. introduced the Beacon Ultra platform at the American Society for Cell Biology annual meeting. This single-cell functional proteomics system enables real-time antibody profiling and functional characterization of thousands of individual cells, streamlining biologic drug development and improving candidate selection
- In October 2024, Fluidigm Corporation (now Standard BioTools) unveiled CyTOF XT, a next-generation single-cell mass cytometry instrument, at the Human Cell Atlas conference. It boosts sample throughput and detection sensitivity, supports up to 60 markers, and offers automated workflows for in-depth immune cell phenotyping
- In September 2024, Parse Biosciences launched the EverCode TCR Profiling Kit, designed for high-throughput analysis of T-cell receptor sequences across thousands of single cells. Compatible with EverCode barcoding technology, it aids in immunology, vaccine development, and immune-oncology research. Parse also plans to expand into B-cell receptor and CRISPR screening in early 2025
